Cargando…
Deep Learning-Based Diagnosis of Alzheimer’s Disease
Alzheimer’s disease (AD), the most familiar type of dementia, is a severe concern in modern healthcare. Around 5.5 million people aged 65 and above have AD, and it is the sixth leading cause of mortality in the US. AD is an irreversible, degenerative brain disorder characterized by a loss of cogniti...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143671/ https://www.ncbi.nlm.nih.gov/pubmed/35629237 http://dx.doi.org/10.3390/jpm12050815 |
_version_ | 1784715863240212480 |
---|---|
author | Saleem, Tausifa Jan Zahra, Syed Rameem Wu, Fan Alwakeel, Ahmed Alwakeel, Mohammed Jeribi, Fathe Hijji, Mohammad |
author_facet | Saleem, Tausifa Jan Zahra, Syed Rameem Wu, Fan Alwakeel, Ahmed Alwakeel, Mohammed Jeribi, Fathe Hijji, Mohammad |
author_sort | Saleem, Tausifa Jan |
collection | PubMed |
description | Alzheimer’s disease (AD), the most familiar type of dementia, is a severe concern in modern healthcare. Around 5.5 million people aged 65 and above have AD, and it is the sixth leading cause of mortality in the US. AD is an irreversible, degenerative brain disorder characterized by a loss of cognitive function and has no proven cure. Deep learning techniques have gained popularity in recent years, particularly in the domains of natural language processing and computer vision. Since 2014, these techniques have begun to achieve substantial consideration in AD diagnosis research, and the number of papers published in this arena is rising drastically. Deep learning techniques have been reported to be more accurate for AD diagnosis in comparison to conventional machine learning models. Motivated to explore the potential of deep learning in AD diagnosis, this study reviews the current state-of-the-art in AD diagnosis using deep learning. We summarize the most recent trends and findings using a thorough literature review. The study also explores the different biomarkers and datasets for AD diagnosis. Even though deep learning has shown promise in AD diagnosis, there are still several challenges that need to be addressed. |
format | Online Article Text |
id | pubmed-9143671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91436712022-05-29 Deep Learning-Based Diagnosis of Alzheimer’s Disease Saleem, Tausifa Jan Zahra, Syed Rameem Wu, Fan Alwakeel, Ahmed Alwakeel, Mohammed Jeribi, Fathe Hijji, Mohammad J Pers Med Review Alzheimer’s disease (AD), the most familiar type of dementia, is a severe concern in modern healthcare. Around 5.5 million people aged 65 and above have AD, and it is the sixth leading cause of mortality in the US. AD is an irreversible, degenerative brain disorder characterized by a loss of cognitive function and has no proven cure. Deep learning techniques have gained popularity in recent years, particularly in the domains of natural language processing and computer vision. Since 2014, these techniques have begun to achieve substantial consideration in AD diagnosis research, and the number of papers published in this arena is rising drastically. Deep learning techniques have been reported to be more accurate for AD diagnosis in comparison to conventional machine learning models. Motivated to explore the potential of deep learning in AD diagnosis, this study reviews the current state-of-the-art in AD diagnosis using deep learning. We summarize the most recent trends and findings using a thorough literature review. The study also explores the different biomarkers and datasets for AD diagnosis. Even though deep learning has shown promise in AD diagnosis, there are still several challenges that need to be addressed. MDPI 2022-05-18 /pmc/articles/PMC9143671/ /pubmed/35629237 http://dx.doi.org/10.3390/jpm12050815 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Saleem, Tausifa Jan Zahra, Syed Rameem Wu, Fan Alwakeel, Ahmed Alwakeel, Mohammed Jeribi, Fathe Hijji, Mohammad Deep Learning-Based Diagnosis of Alzheimer’s Disease |
title | Deep Learning-Based Diagnosis of Alzheimer’s Disease |
title_full | Deep Learning-Based Diagnosis of Alzheimer’s Disease |
title_fullStr | Deep Learning-Based Diagnosis of Alzheimer’s Disease |
title_full_unstemmed | Deep Learning-Based Diagnosis of Alzheimer’s Disease |
title_short | Deep Learning-Based Diagnosis of Alzheimer’s Disease |
title_sort | deep learning-based diagnosis of alzheimer’s disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143671/ https://www.ncbi.nlm.nih.gov/pubmed/35629237 http://dx.doi.org/10.3390/jpm12050815 |
work_keys_str_mv | AT saleemtausifajan deeplearningbaseddiagnosisofalzheimersdisease AT zahrasyedrameem deeplearningbaseddiagnosisofalzheimersdisease AT wufan deeplearningbaseddiagnosisofalzheimersdisease AT alwakeelahmed deeplearningbaseddiagnosisofalzheimersdisease AT alwakeelmohammed deeplearningbaseddiagnosisofalzheimersdisease AT jeribifathe deeplearningbaseddiagnosisofalzheimersdisease AT hijjimohammad deeplearningbaseddiagnosisofalzheimersdisease |